Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
West Virginia University
West Virginia University
University of Manitoba
Alexandria University
Assistance Publique - Hôpitaux de Paris
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Augusta University
Instituto Nacional de Cancerologia de Mexico
Universitaire Ziekenhuizen KU Leuven
University of Nebraska
Universitaire Ziekenhuizen KU Leuven
Rush University Medical Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Paris 13
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Indonesia University
Amsterdam UMC, location VUmc
Cellerant Therapeutics
Wake Forest University Health Sciences
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
German CLL Study Group
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mashhad University of Medical Sciences
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Enzon Pharmaceuticals, Inc.
Northwestern University
Mayo Clinic
Amgen
National Institutes of Health Clinical Center (CC)